CCR4 and mature T-cell and NK-cell non-Hodgkin lymphoma: A phase I clinical study (0761–0501 Study: ClinicalTrials.gov Identifier NCT00355472) has been conducted in patients with CCR4-positive relapsed PTCL, including ATL [43•].